Recruiting

Observational Study

Sponsor:

Boston Children's Hospital

Code:

NCT03501667

Conditions

Pediatric Rheumatological Condition (i.e., Arthritis, SLE, Kawasaki's Disaese)

Eligibility Criteria

Sex: All

Age: 25+

Healthy Volunteers: Not accepted

Interventions

Use of decision support tool

Use of UpToDate

Study Details

Brief summary:

Boston Children's Hospital resources include SimulConsult which is a decision support tool available for use of BCH provider through the library portal. It is offered along other resources on that webpage (UpToDate, Micromedex, and VisualDx). See addendum 1.

Recently, a pediatric rheumatology arm was added to the expertise of SimulConsult, guided by our co-PI, Dr. Robert Sundel. As this tool is being offered and used, the investigators would like to assess metric of performance of this tool in enhancing participant trainees knowledge about the work up of patients with a potential rheumatologic disorder. See also www.ncbi.nlm.gov/pubmed/27964737 The investigators are conducting a clinical research to assess improvement in the clinical performance of study participants evaluating patients with a potential rheumatologic disorder. The intervention involved in using a computerized decision support tool already available in the Boston Children's Hospital domain. The outcome will be comparing this performance to that of an attending physician as the gold standard. We will assess the study participants performance across two locations: Emergency Department and Rheumatology clinic. Care to patients remains unchanged, as the workup plan and care is provided by an attending across both domains.

The investigators main hypothesis is that using a decision support tool will result in a higher agreement rate between study participants' differential diagnosis and work up plan compared with the gold standard (attending differential diagnosis and research plan).

Conditions

Pediatric Rheumatological Condition (i.e., Arthritis, SLE, Kawasaki's Disaese)

Study ID

NCT03501667

Start date

Jan 1, 2020

Status verified date

Jul, 2020

Completion date

Dec 31, 2020

Anticipated

Primary completion date

Sep 30, 2020

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 25+

Healthy Volunteers: Not accepted

Inclusion Criteria:

A trainee at Boston Children's residency program (pediatrics, emergency medicine, pediatric emergency medicine, pediatric rheumatology)

Exclusion Criteria:

Opting out of the study (optional at any stage)

Study Design

Enrollment

900 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Diagnostic

Interventions and Outcome Measures

Arms

active comparator: Use of decision support tool

Trainee using decision support tool while assessing a clinical case. This intervention will affect the study participant fund of knowledge on the case.

active comparator: Use of UpToDate

Control group, participants using current literature prior to assessing a clinical case. Allowing 10 minutes to read on a topic during clinical care is an active intervention in the study participant fund of knowledge.

Interventions

Use of decision support tool

use of a decision support software during clinical assessment of a case

Use of UpToDate

Control group, participants using current literature prior to assessing a clinical case. Allowing 10 minutes to read on a topic during clinical care is an active intervention in the study participant fund of knowledge.

Primary outcome measure

  • Comparing DDx with that of the attending physician (gold standard) [ Time Frame: through study completion, an average of 1 year ]
  • Comparing evaluation plan with that of the attending physician (gold standard) [ Time Frame: through study completion, an average of 1 year ]

Central Contacts and Locations

Locations

Boston Children's Hospital

Recruiting

Boston, Massachusetts, United States, 02115

Contacts

More Information

Sponsor

Boston Children's Hospital

Last update posted

Jul 7, 2020

Last verified

Jul, 2020

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Boston Children's Hospital on 2020-07-07.